May 19, 2016
New Clinical Trial Data in Advanced Melanoma Presented at ASCO 2018: How Will it Change How You Practice?
Video Categories: 2018 ASCO Insights and Video LibraryDr Sanjiv Agarwala talks about exciting new results presented at ASCO 2018 in melanoma, including the durability of anti–PD-1 therapy in providing 40% overall survival at 5 years, updates on adjuvant therapy showing superiority of anti–PD-1 over anti–CTLA-4, and new results in combining immunotherapies.
Related Videos
March 31, 2015
Precision Medicine for CLL
Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side [ Read More ]
August 15, 2016
Carcinoid Heart Disease
Richard Parker, MD, provides an overview of this condition, which is common on patients with carcinoid syndrome.Â